Study to Investigate a New Drug in Healthy Subjects (SAD,MAD)

• Research type

  Research Study

• Full title

  A blinded, placebo-controlled, dose-escalation, Phase 1 study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple doses of ISIS 494372 administered subcutaneously to healthy volunteers

• IRAS ID

  121394

• Sponsor organisation

  Isis Pharmaceuticals, Inc.

• Eudract number

  2012-004909-27

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• Research summary

  Permission to publish Research Summary refused by researcher

• REC name

  South Central - Berkshire Research Ethics Committee

• REC reference

  13/SC/0011

• Date of REC Opinion

  30 Jan 2013

• REC opinion

  Favourable Opinion